vs
AdvanSix Inc.（ASIX）与ASP Isotopes Inc.（ASPI）财务数据对比。点击上方公司名可切换其他公司
AdvanSix Inc.的季度营收约是ASP Isotopes Inc.的21.6倍（$359.9M vs $16.7M）。ASP Isotopes Inc.同比增速更快（1295.7% vs 9.4%）。AdvanSix Inc.自由现金流更多（$36.1M vs $-47.4M）。过去两年ASP Isotopes Inc.的营收复合增速更高（345.2% vs 3.4%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
ASIX vs ASPI — 直观对比
营收规模更大
ASIX
是对方的21.6倍
$16.7M
营收增速更快
ASPI
高出1286.3%
9.4%
自由现金流更多
ASIX
多$83.6M
$-47.4M
两年增速更快
ASPI
近两年复合增速
3.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $16.7M |
| 净利润 | $-2.8M | — |
| 毛利率 | 7.6% | 12.5% |
| 营业利润率 | -0.7% | — |
| 净利率 | -0.8% | — |
| 营收同比 | 9.4% | 1295.7% |
| 净利润同比 | -892.9% | -586.8% |
| 每股收益（稀释后） | $-0.11 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXASPI
| Q4 25 | $359.9M | $16.7M | ||
| Q3 25 | $374.5M | $4.9M | ||
| Q2 25 | $410.0M | $1.2M | ||
| Q1 25 | $377.8M | $1.1M | ||
| Q4 24 | $329.1M | $1.2M | ||
| Q3 24 | $398.2M | $1.1M | ||
| Q2 24 | $453.5M | $1.0M | ||
| Q1 24 | $336.8M | $840.4K |
净利润ASIXASPI
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.6M | $-12.9M | ||
| Q2 25 | $31.4M | $-75.2M | ||
| Q1 25 | $23.3M | $-8.5M | ||
| Q4 24 | $352.0K | — | ||
| Q3 24 | $22.3M | $-7.4M | ||
| Q2 24 | $38.9M | $-8.9M | ||
| Q1 24 | $-17.4M | $-7.0M |
毛利率ASIXASPI
| Q4 25 | 7.6% | 12.5% | ||
| Q3 25 | 6.8% | 8.7% | ||
| Q2 25 | 14.3% | 47.7% | ||
| Q1 25 | 14.2% | 29.7% | ||
| Q4 24 | 3.4% | 50.7% | ||
| Q3 24 | 14.4% | 27.0% | ||
| Q2 24 | 17.9% | 41.2% | ||
| Q1 24 | 0.9% | 33.2% |
营业利润率ASIXASPI
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.9% | -306.1% | ||
| Q2 25 | 7.7% | -998.8% | ||
| Q1 25 | 7.7% | -721.9% | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | 7.5% | -499.6% | ||
| Q2 24 | 11.5% | -729.5% | ||
| Q1 24 | -7.0% | -691.9% |
净利率ASIXASPI
| Q4 25 | -0.8% | — | ||
| Q3 25 | -0.7% | -263.7% | ||
| Q2 25 | 7.7% | -6271.7% | ||
| Q1 25 | 6.2% | -768.1% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.6% | -676.2% | ||
| Q2 24 | 8.6% | -868.8% | ||
| Q1 24 | -5.2% | -828.8% |
每股收益（稀释后）ASIXASPI
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | $-0.15 | ||
| Q2 25 | $1.15 | $-1.03 | ||
| Q1 25 | $0.86 | $-0.12 | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.82 | $-0.12 | ||
| Q2 24 | $1.43 | $-0.24 | ||
| Q1 24 | $-0.65 | $-0.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $333.3M |
| 总债务越低越好 | — | $14.4M |
| 股东权益账面价值 | $815.2M | $204.2M |
| 总资产 | $1.7B | $498.0M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资ASIXASPI
| Q4 25 | $19.8M | $333.3M | ||
| Q3 25 | $23.7M | $113.9M | ||
| Q2 25 | $18.4M | $67.7M | ||
| Q1 25 | $8.3M | $56.0M | ||
| Q4 24 | $19.6M | $61.9M | ||
| Q3 24 | $17.3M | $51.6M | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $20.6M | — |
总债务ASIXASPI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $13.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASIXASPI
| Q4 25 | $815.2M | $204.2M | ||
| Q3 25 | $818.2M | $74.1M | ||
| Q2 25 | $823.7M | $25.2M | ||
| Q1 25 | $794.4M | $42.5M | ||
| Q4 24 | $774.6M | $47.9M | ||
| Q3 24 | $766.4M | $38.7M | ||
| Q2 24 | $746.6M | $11.0M | ||
| Q1 24 | $713.2M | $10.5M |
总资产ASIXASPI
| Q4 25 | $1.7B | $498.0M | ||
| Q3 25 | $1.7B | $225.9M | ||
| Q2 25 | $1.6B | $135.9M | ||
| Q1 25 | $1.6B | $90.9M | ||
| Q4 24 | $1.6B | $94.3M | ||
| Q3 24 | $1.5B | $84.1M | ||
| Q2 24 | $1.5B | $54.8M | ||
| Q1 24 | $1.5B | $45.4M |
负债/权益比ASIXASPI
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $-37.8M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | $-47.4M |
| 自由现金流率自由现金流/营收 | 10.0% | -284.7% |
| 资本支出强度资本支出/营收 | 7.7% | 57.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $6.4M | $-74.6M |
8季度趋势，按日历期对齐
经营现金流ASIXASPI
| Q4 25 | $63.7M | $-37.8M | ||
| Q3 25 | $26.6M | $-8.9M | ||
| Q2 25 | $21.1M | $-7.9M | ||
| Q1 25 | $11.4M | $-3.2M | ||
| Q4 24 | $64.2M | $-16.7M | ||
| Q3 24 | $57.3M | $-4.8M | ||
| Q2 24 | $50.2M | $-5.1M | ||
| Q1 24 | $-36.2M | $-3.0M |
自由现金流ASIXASPI
| Q4 25 | $36.1M | $-47.4M | ||
| Q3 25 | $66.0K | $-12.0M | ||
| Q2 25 | $-7.2M | $-9.7M | ||
| Q1 25 | $-22.6M | $-5.5M | ||
| Q4 24 | $29.8M | $-26.4M | ||
| Q3 24 | $26.8M | $-9.3M | ||
| Q2 24 | $16.7M | $-7.7M | ||
| Q1 24 | $-71.6M | $-4.2M |
自由现金流率ASIXASPI
| Q4 25 | 10.0% | -284.7% | ||
| Q3 25 | 0.0% | -245.5% | ||
| Q2 25 | -1.7% | -809.4% | ||
| Q1 25 | -6.0% | -497.4% | ||
| Q4 24 | 9.1% | -2209.3% | ||
| Q3 24 | 6.7% | -857.3% | ||
| Q2 24 | 3.7% | -757.8% | ||
| Q1 24 | -21.3% | -501.7% |
资本支出强度ASIXASPI
| Q4 25 | 7.7% | 57.9% | ||
| Q3 25 | 7.1% | 64.4% | ||
| Q2 25 | 6.9% | 150.1% | ||
| Q1 25 | 9.0% | 209.6% | ||
| Q4 24 | 10.4% | 810.5% | ||
| Q3 24 | 7.7% | 412.3% | ||
| Q2 24 | 7.4% | 256.5% | ||
| Q1 24 | 10.5% | 148.3% |
现金转化率ASIXASPI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
ASPI
暂无分部数据
